Medlin Derek

SEC source: 0001628280-26-036677 · wk-form4_1779235128.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,299

F1 · balance_after: On May 6, 2024, the reporting person was granted 20,000 RSUs, one-third of which vested on March 15, 2025, and the remainder scheduled to vest thereafter in eight quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2024 Award").

F2 · balance_after: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2024 Award.

SEC source: 0000950103-26-003439 · dp242975_4-medlin.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,921

F1 · shares: On March 15, 2022, the reporting person was granted 592,946 RSUs (which, following the Issuer's July 27, 2023 1-for-25 reverse stock split, resulted in 23,718 RSUs), 25% of which vested on March 15, 2023, with the remainder scheduled to vest thereafter in 12 quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2022 Award").

F2 · shares: On June 16, 2023, the reporting person was granted 385,000 RSUs (which, following the Issuer's July 27, 2023 1-for-25 reverse stock split, resulted in 15,400 RSUs), one-third of which vested on March 15, 2024, and the remainder scheduled to vest thereafter in eight quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2023 Award").

F3 · shares: On May 6, 2024, the reporting person was granted 20,000 RSUs, one-third of which vested on March 15, 2025, and the remainder scheduled to vest thereafter in eight quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2024 Award").

F4 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2022 Award, 2023 Award and 2024 Award.

SEC source: 0000950103-25-015056 · dp237716_4-medlin.xml · nonDerivative · entry 9

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,811

F8 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2022 Award, 2023 Award and 2024 Award.

SEC source: 0000950103-25-015056 · dp237716_4-medlin.xml · nonDerivative · entry 8

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,741

F8 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2022 Award, 2023 Award and 2024 Award.

SEC source: 0000950103-25-015056 · dp237716_4-medlin.xml · nonDerivative · entry 7

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,398

F8 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2022 Award, 2023 Award and 2024 Award.

SEC source: 0000950103-25-015056 · dp237716_4-medlin.xml · nonDerivative · entry 6

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,054

F6 · shares: On May 6, 2024, the reporting person was granted 20,000 RSUs, one-third of which vested on March 15, 2025, and the remainder scheduled to vest thereafter in eight quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2024 Award").

F7 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2021 Award, 2022 Award and 2024 Award.

SEC source: 0000950103-25-015056 · dp237716_4-medlin.xml · nonDerivative · entry 5

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,707

F5 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2021 Award, 2022 Award and 2023 Award.

SEC source: 0000950103-25-015056 · dp237716_4-medlin.xml · nonDerivative · entry 4

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,006

F5 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2021 Award, 2022 Award and 2023 Award.

SEC source: 0000950103-25-015056 · dp237716_4-medlin.xml · nonDerivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,143

F5 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2021 Award, 2022 Award and 2023 Award.

SEC source: 0000950103-25-015056 · dp237716_4-medlin.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,281

F4 · shares: On June 16, 2023, the reporting person was granted 385,000 RSUs (which, following the Issuer's July 27, 2023 1-for-25 reverse stock split, resulted in 15,400 RSUs), one-third of which vested on March 15, 2024, and the remainder scheduled to vest thereafter in eight quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2023 Award").

F5 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2021 Award, 2022 Award and 2023 Award.

SEC source: 0000950103-24-006470 · dp211013_4-medlin.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,041

F1 · shares: Award of restricted stock units ("RSUs") that will vest over three years, with 33% of the RSUs vesting on March 15, 2025, and the remaining RSUs vesting thereafter in 8 substantially equal quarterly installments on the 15th of each of February, May, August and November of each year, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-24-011964 · wk-form4_1710885544.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,041

F1 · shares: Shares reported were withheld for the payment of taxes associated with the vesting of one-third of an award of RSUs originally granted on June 16, 2023.

SEC source: 0001628280-24-005965 · wk-form4_1708553666.xml · derivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,377

Underlying: Common Stock · 276 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

F3 · derivative.exercise_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

F3 · derivative.expiration_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-24-005965 · wk-form4_1708553666.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,959

F2 · shares: Shares reported were withheld for the payment of taxes associated with the quarterly vesting of 6.25% of an award of RSUs originally granted on September 9, 2021 and March 15, 2022.

SEC source: 0001628280-24-005965 · wk-form4_1708553666.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,709

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

SEC source: 0001628280-23-039549 · wk-form4_1700265869.xml · derivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,653

Underlying: Common Stock · 552 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

F3 · derivative.exercise_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

F3 · derivative.expiration_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-23-039549 · wk-form4_1700265869.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,433

F2 · shares: Shares reported were withheld for the payment of taxes associated with the quarterly vesting of 6.25% of awards of RSUs originally granted on September 9, 2021 and March 15, 2022.

SEC source: 0001628280-23-039549 · wk-form4_1700265869.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,746

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

SEC source: 0000950103-25-015056 · dp237716_4-medlin.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,399

F1 · shares: On September 9, 2021, the reporting person was granted 110,213 restricted stock units ("RSUs") (which, following the Issuer's July 27, 2023 1-for-25 reverse stock split, resulted in 4,409 RSUs), 25% of which vested on March 15, 2022, with the remainder scheduled to vest thereafter in 12 quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2021 Award"). The reporting person has reported prior grants of RSUs under the 2021 Award in Table II of Form 4.

F2 · shares: On March 15, 2022, the reporting person was granted 592,946 RSUs (which, following the Issuer's July 27, 2023 1-for-25 reverse stock split, resulted in 23,718 RSUs), 25% of which vested on March 15, 2023, with the remainder scheduled to vest thereafter in 12 quarterly installments on each of May 15, August 15, November 15 and February 15 subject to the reporting person's continued employment with the Issuer on each applicable vesting date (the "2022 Award").

F3 · shares: The shares reported in Column 4 are shares withheld for the payment of taxes associated with the 2021 Award and 2022 Award and were previously included in the shares reported under Transaction Code F in Table I of the Form 4 filed on November 17, 2023.

SEC source: 0001628280-23-022944 · wk-form4_1687383856.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,254,832

F1 · shares: One-third (1/3) of the RSUs will vest on March 15, 2024. The remaining RSUs will vest in eight substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-23-018694 · wf-form4_168435441436118.xml · derivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,107

Underlying: Common Stock · 6,888 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

F3 · derivative.exercise_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

F3 · derivative.expiration_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-23-018694 · wf-form4_168435441436118.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 869,832

F2 · shares: Shares reported were withheld for the payment of taxes associated with the quarterly vesting of 6.25% of awards of RSUs originally granted on September 9, 2021 and March 15, 2022.

SEC source: 0001628280-23-018694 · wf-form4_168435441436118.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 880,533

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

SEC source: 0001628280-23-008482 · wf-form4_167908397027934.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 873,645

F1 · shares: Shares reported were withheld for the payment of taxes associated with the vesting of 25% of an award of RSUs originally granted on March 15, 2022.

SEC source: 0001628280-23-004040 · wf-form4_167666908906080.xml · derivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,995

Underlying: Common Stock · 6,888 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

F3 · derivative.exercise_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

F3 · derivative.expiration_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-23-004040 · wf-form4_167666908906080.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 909,741

F2 · shares: Shares reported were withheld for the payment of taxes associated with the quarterly vesting of 6.25% of an award of RSUs originally granted on September 9, 2021.

SEC source: 0001628280-23-004040 · wf-form4_167666908906080.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 911,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

SEC source: 0001628280-22-030331 · wf-form4_166872119652928.xml · derivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,883

Underlying: Common Stock · 6,889 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15, 2022. The remaining RSUs will vest in in twelve substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15, 2022. The remaining RSUs will vest in in twelve substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-22-030331 · wf-form4_166872119652928.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 904,902

F2 · shares: Shares reported were withheld for the payment of taxes associated with the quarterly vesting of 6.25% of an award of RSUs originally granted on September 9, 2021.

SEC source: 0001628280-22-030331 · wf-form4_166872119652928.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 906,580

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

SEC source: 0001628280-22-023169 · wf-form4_166076972986229.xml · derivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,772

Underlying: Common Stock · 6,888 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

F3 · derivative.exercise_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

F3 · derivative.expiration_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-22-023169 · wf-form4_166076972986229.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 899,691

F2 · shares: Shares reported were withheld for the payment of taxes associated with the quarterly vesting of 6.25% of an award of RSUs originally granted on September 9, 2021.

SEC source: 0001628280-22-023169 · wf-form4_166076972986229.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 901,369

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

SEC source: 0001628280-22-014792 · wf-form4_165291411425059.xml · derivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,548

Underlying: Common Stock · 6,888 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

F3 · derivative.exercise_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

F3 · derivative.expiration_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining unvested RSUs will vest in eleven substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-22-014792 · wf-form4_165291411425059.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 894,481

F2 · shares: Shares reported were withheld for the payment of taxes associated with the quarterly vesting of 6.25% of an award of RSUs originally granted on September 9, 2021.

SEC source: 0001628280-22-014792 · wf-form4_165291411425059.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 896,159

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

SEC source: 0001628280-22-006616 · wf-form4_164756094102806.xml · derivative · entry 4

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,660

Underlying: Common Stock · 27,553 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

F4 · derivative.exercise_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining 82,660 unvested RSUs will vest in twelve substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

F4 · derivative.expiration_date: On September 9, 2021, the Reporting Person was granted RSUs, of which the remaining 82,660 unvested RSUs will vest in twelve substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-22-006616 · wf-form4_164756094102806.xml · nonDerivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 889,271

F3 · shares: Restricted stock unit award that will vest over four years, with 25% of the RSUs vesting on March 15, 2023, and the remaining RSUs vesting in twelve substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001628280-22-006616 · wf-form4_164756094102806.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 296,325

F2 · shares: Shares reported were withheld for the payment of taxes associated with the vesting of 25% of an award of RSUs originally granted on September 9, 2021.

SEC source: 0001628280-22-006616 · wf-form4_164756094102806.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units ("RSUs") convert into shares of the Issuer's Common Stock on a one-for-one basis. The transaction represents the settlement of vested RSUs in shares of the Issuer's Common Stock.

SEC source: 0001213900-21-047848 · ownership.xml · derivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,213

Underlying: Common Stock · 110,213 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: 25% of the RSUs will vest on March 15, 2022. The remaining RSUs will vest in in twelve substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

F2 · derivative.expiration_date: 25% of the RSUs will vest on March 15, 2022. The remaining RSUs will vest in in twelve substantially equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.

SEC source: 0001213900-21-042346 · ownership.xml · nonDerivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,482

SEC source: 0001213900-21-042346 · ownership.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,382

SEC source: 0001213900-21-032408 · ownership.xml · derivative · entry 5

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 702,914

Underlying: Common Stock · 702,914 shares

Expires 2029-09-04

SEC source: 0001213900-21-032408 · ownership.xml · derivative · entry 4

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,671

Underlying: Common Stock · 204,671 shares

Expires 2029-09-04

SEC source: 0001213900-21-032408 · ownership.xml · derivative · entry 3

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,612

Underlying: Common Stock · 94,612 shares

Expires 2028-07-31

SEC source: 0001213900-21-032408 · ownership.xml · derivative · entry 2

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,646

Underlying: Common Stock · 79,646 shares

Expires 2027-07-30

SEC source: 0001213900-21-032408 · ownership.xml · nonDerivative · entry 1

Medlin Derek · CIK 0001866031 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,482

F1 · kind: Shares were acquired pursuant to Katapult Holdings, Inc.'s (the "Issuer") initial business combination in exchange for shares of the legacy Katapult Holdings, Inc. entity that were owned by the reporting person prior to the Closing.

F2 · shares: Includes earn out shares granted in connection with the Issuer's initial business combination, subject to certain vesting provisions.

F1 · price: Shares were acquired pursuant to Katapult Holdings, Inc.'s (the "Issuer") initial business combination in exchange for shares of the legacy Katapult Holdings, Inc. entity that were owned by the reporting person prior to the Closing.

F2 · balance_after: Includes earn out shares granted in connection with the Issuer's initial business combination, subject to certain vesting provisions.